315 related articles for article (PubMed ID: 25268406)
1. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
Woo JH; Kim H; Kim JH; Kim JG
Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.
Zhang C; Ma J; Chen G; Fu D; Li L; Li M
Osteoporos Int; 2015 Dec; 26(12):2803-10. PubMed ID: 26055357
[TBL] [Abstract][Full Text] [Related]
3. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women.
Kim J; Kim H; Ku SY; Suh CS; Kim JH; Kim JG
Climacteric; 2016; 19(1):85-90. PubMed ID: 26624862
[TBL] [Abstract][Full Text] [Related]
5. Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women.
Lee HJ; Kim H; Ku SY; Choi YM; Kim JH; Kim JG
Menopause; 2014 Jan; 21(1):67-73. PubMed ID: 23760429
[TBL] [Abstract][Full Text] [Related]
6. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
7. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
8. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms in period genes and bone density in postmenopausal Korean women.
Kim H; Koh H; Ku SY; Kim SH; Kim JH; Kim JG
Climacteric; 2014 Oct; 17(5):605-12. PubMed ID: 24678593
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
11. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
[TBL] [Abstract][Full Text] [Related]
12. TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women.
Mencej-Bedrač S; Preželj J; Marc J
Maturitas; 2011 Jul; 69(3):263-7. PubMed ID: 21411255
[TBL] [Abstract][Full Text] [Related]
13. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
14. Non-association between polymorphisms of the frizzled receptor genes and bone mineral density in postmenopausal Korean women.
Kim JG; Kim H; Jee BC; Suh CS; Choi YM; Moon SY
J Korean Med Sci; 2009 Jun; 24(3):443-7. PubMed ID: 19543507
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in neuropeptide genes and bone mineral density in Korean postmenopausal women.
Chun EH; Kim H; Suh CS; Kim JH; Kim DY; Kim JG
Menopause; 2015 Nov; 22(11):1256-63. PubMed ID: 25871004
[TBL] [Abstract][Full Text] [Related]
16. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women.
Choi JY; Shin A; Park SK; Chung HW; Cho SI; Shin CS; Kim H; Lee KM; Lee KH; Kang C; Cho DY; Kang D
Calcif Tissue Int; 2005 Sep; 77(3):152-9. PubMed ID: 16151677
[TBL] [Abstract][Full Text] [Related]
18. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
19. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women.
Feng G; Meng L; Wang H; Lu Y; Jia J; Zhang Y; Zhang H; Zhang B
J Pediatr Endocrinol Metab; 2012; 25(11-12):1141-4. PubMed ID: 23329761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
